Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «pharma»

17 October, 2017 7:35 AM Buy Aurobindo Pharma, Ashok Leyland, Century Textiles: Gaurav Bissa

Gaurav Bissa of LKP Securities recommends buying Aurobindo Pharma, Ashok Leyland and Century Textiles and Industries. Gaurav Bissa of LKP Securities told CNBC-TV18, "The first recommendation would be a buy on Aurobindo Pharma. If you look at it for the last 5-7 trading sessions, there was a lot of short-coverings that we saw and it propelled the stock 19

17 October, 2017 2:35 AM Nifty likely to open lower with crucial support at 10150; buy Sun Pharma, Tata Motors: Prakash Gaba

The bulls charged on D-Street on the first day of Diwali week. The Nifty made a bullish candle for the third consecutive day in a row on Monday. It made a new record high as it broke out of trading range with buying across segments. The Nifty managed to close above 10200 mark after two and a half months. The Nifty closed at 10,230.8 on Monday. According 22

13 October, 2017 5:45 PM Telangana government wants slice of summit pie

Hyderabad: The Telangana state government wants a special session for itself during the ensuing Global Entrepreneurship Summit to showcase investment opportunities in the state. The event will be inaugurated by Prime Minister Narendra Modi on November 26, and US President Donald Trump’s daughter Ivanka will lead the US delegation. Chief Minister K. Chandrasekhar 32

13 October, 2017 10:51 AM Nifty at record closing high ahead of Diwali, Sensex rallies 250 pts but Midcap flat

The Nifty 50 ended at fresh record closing high on Friday as investors cheered macro data, earnings and telcos deals. The rally was driven by banks, telecom and metals stocks, and Reliance Industries. But the broader markets underperformed benchmarks, ending flat. The 50-share NSE Nifty rose 71.10 points or 0.70 percent to 10,167.50, after hitting a fresh 39

12 October, 2017 4:40 PM Sun Pharma to increase stake in Ranbaxy Malaysia to 79.5 %

Drug major Sun Pharmaceutical Industries on Thursday said that it will increase stake in its subsidiary Ranbaxy Malaysia Sdn Bhd to 79.5 percent through purchase of shares. One of the wholly-owned subsidiaries of the company has agreed to increase its shareholding in Ranbaxy Malaysia Sdn Bhd by 8.3 percent by way of purchase of around 6.66 lakh shares 35

12 October, 2017 1:33 PM Sensex catapults to over 348 points, Nifty eyes 10,100-mark

The broader NSE Nifty ended up 1.12 percent at 10,096.40 while the benchmark BSE Sensex closed 1.09 percent higher at 32,182.22. Mumbai: Buoyed by positive global cues and healthy buying in metals, banking and automobile stocks, key Indian equity indices provisionally closed on a higher note on Thursday. Paring the previous day`s losses, the equity indices 34

11 October, 2017 5:13 AM Buy Coromandel Intl, Ashok Leyland, IGL, Edelweiss, Jubilant Food: Ashwani Gujral

Ashwani Gujral of recommends buying Coromandel International, Ashok Leyland, IGL, Edelweiss Financial Services and Jubilant Foodworks. Ashwani Gujral of told CNBC-TV18, "Fertiliser did extremely well yesterday. So, Coromandel International is a buy with a stop loss of Rs 470 for target of Rs 495." "Ashok Leyland has restarted 28

9 October, 2017 8:14 AM Market Live: Nifty remains below 10K amid consolidation ahead of Q2 earnings

2:38 pm Loan for green projects: Anil Ambani led Reliance Capital arm will get a loan assistance of Rs 300 crore from government body IREDA to utilise funds for on-lending to renewable energy sector. "Reliance Money (a brand of Reliance Commercial Finance or RCFL) signs Rs 300 crore agreement with Indian Renewable Energy Development Agency Ltd (IREDA) 46

5 October, 2017 12:11 PM Nusli Wadia richest newcomer on Forbes India Rich List

NEW DELHI: Cookies-and-airline tycoon Nusli Wadia is the wealthiest newcomer with a net worth of USD 5.6 billion at the 25th position on the Forbes' richest Indians list that was topped by Reliance Industries chief Mukesh Ambani for the 10th straight year. Though there has been a significant rise in the number of billionaires, but only six could make the cut in the top 100 club on the Forbes 18

4 October, 2017 4:30 PM Fosun buys 74% in Gland Pharma

Chinese drug firm Fosun Pharma has acquired approximately 74% in Hyderabad-based Gland Pharma at a valuation of not more than $1.09 billion, the company said. Shanghai Fosun Pharmaceutical (Group) Co. Ltd. had, in July last year, announced plans to acquire 86.08% stake in Gland Pharma for not more than $1.26 billion. However, the Cabinet Committee on Economic 7